Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesResonance Health Ltd

Resonance Health Ltd

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.09 AUD -0.00 ( 1.10%)
Last update at 2026-11-12T05:10:00Z
VOLUME
1994989
Market Cap
36.26M

Momentum Score

…

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; HepaFatSmart, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFatSmart into a consolidated report; and CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading. It also provides phantoms comprising FerriScan, T1CMR, and T2CMR phantoms for the calibration of MRI machines. In addition, the company operates as an imaging contract research organization that provides comprehensive proposal and project management support, site set-up, imaging charter development, clinical reports, data transfer agreements, and compliance services for clinical trial sponsors. It serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.09
Low
0.10
High
52 Week Price Range
0.04
Low
0.09
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Resonance Health Ltd provides non-invasive quantitative MRI diagnostics and associated software, notably liver iron measurement (FerriScan) and liver fat assessment, to clinicians and imaging networks internationally. Long-term growth drivers include increasing recognition of iron overload and fatty liver disease, wider adoption of quantitative imaging, and scalability of centralized analysis plus software licensing, which may benefit recurring revenue and clinical uptake. These attributes could make the company attractive as a niche diagnostics provider with established clinical utility.
Key risks include dependence on a narrow product portfolio and small commercial scale, exposure to regulatory and reimbursement changes, competitive pressure from alternative imaging methods, and execution risk from geographic expansion.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.09
Dividend Yield
-
Revenue TTM
15.75M
Revenue Per Share
0.03
Gross Profit TTM
15.21M
Debt / Equity
0.34
ROE
14.76%
Net Debt
-1.04M
ROCE
12.59%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 1.10M -2.20M -0.63M -1.26M -1.55M
Net income 1.51M -1.73M 0.17M -0.78M -1.14M
Selling general administrative - 2.85M 4.55M 3.14M 2.50M
Selling and marketing expenses - 0.86M 0.90M 0.82M 1.02M
Gross profit 14.80M 11.07M 8.59M 4.40M 3.83M
Reconciled depreciation - - 0.50M 0.44M 0.43M
Ebit 1.53M -1.58M -0.88M -1.59M -1.77M
Ebitda 2.48M -1.41M -0.38M -1.16M -1.34M
Depreciation and amortization 0.95M 0.18M 0.50M 0.44M 0.43M
Operating income 1.53M -1.93M -0.88M -1.59M -1.77M
Other operating expenses 14.22M 10.84M 9.47M 6.03M 5.60M
Interest expense 0.34M 0.32M - - 0.00M
Tax provision - -0.47M -0.80M -0.48M -0.41M
Interest income - 0.28M 0.14M 0.29M 0.00M
Net interest income - - 0.14M 0.04M 0.00M
Income tax expense -0.41M 0.47M -0.80M -0.48M -0.41M
Total revenue 15.75M 11.07M 8.59M 4.40M 3.83M
Total operating expenses 13.27M 10.84M 8.20M 6.03M 5.60M
Cost of revenue 0.95M 0.96M - - -
Total other income expense net -0.43M -0.27M 0.25M 0.32M 0.22M
Net income from continuing ops - - 0.17M -0.78M -1.14M
Net income applicable to common shares - -1.73M 0.17M -0.78M -1.14M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 18.74M 17.89M 20.28M 10.98M 11.69M
Intangible assets 3.98M 1.72M - 2.71M 2.87M
Other current assets 0.14M 1.04M 0.11M - 0.06M
Total liab 7.63M 8.50M 9.35M 1.05M 1.00M
Total stockholder equity 11.11M 9.39M 10.93M 9.94M 10.69M
Deferred long term liab - - - 2.71M 2.87M
Other current liab 1.78M 4.30M 5.34M 0.01M 0.46M
Common stock 74.67M 74.45M 74.17M 73.88M 73.88M
Capital stock - - - 73.88M 73.88M
Retained earnings -63.50M -67.61M -65.87M -66.04M -65.26M
Good will 5.27M 5.27M 7.26M - -
Other assets - - - 2.80M 2.95M
Cash 4.85M 2.98M 3.40M 6.36M 6.78M
Cash and equivalents - - - 1.04M 6.78M
Total current liabilities 6.58M 5.18M 6.15M 0.88M 0.81M
Current deferred revenue 1.23M - 0.01M 0.62M 0.02M
Net debt -1.04M 0.83M 0.29M -6.09M -6.51M
Short term debt 2.77M 0.49M 0.49M 0.10M 0.08M
Short long term debt total 3.81M 3.80M 3.70M 0.27M 0.27M
Other stockholder equity - - - -0.27M 2.07M
Property plant equipment - - - 0.63M 0.39M
Total current assets 7.46M 6.61M 9.29M 7.56M 8.35M
Long term investments - - - 0.08M 0.08M
Net tangible assets - - - 9.94M 10.69M
Short term investments - - 3.45M - -
Net receivables 2.47M 2.60M 2.32M 1.14M 1.51M
Accounts payable 0.81M 0.40M 0.30M 0.15M 0.24M
Accumulated other comprehensive income -0.05M 2.54M 2.64M 2.09M 2.07M
Non currrent assets other 0.13M 2.71M 2.73M 0.08M 0.08M
Non current assets total 11.28M 11.27M 11.00M 3.43M 3.34M
Capital lease obligations - - - 0.27M 0.27M
Long term debt total - - - 0.17M 0.19M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -3.94M -0.47M -0.70M
Change to liabilities - - - 0.04M 0.20M
Total cashflows from investing activities -0.30M -4.52M -3.94M -0.47M -0.70M
Net borrowings - - 3.17M -0.08M -0.07M
Total cash from financing activities -0.60M -0.65M 3.01M -0.08M -0.11M
Change to operating activities - - - 0.02M -0.05M
Net income 1.51M -1.73M 0.17M -0.78M -1.14M
Change in cash 1.87M -3.88M 0.49M -0.42M 2.99M
Begin period cash flow 2.98M 6.85M 6.36M 6.78M 8.86M
End period cash flow 4.85M 2.98M 6.85M 6.36M 6.78M
Total cash from operating activities 2.88M 1.25M 1.39M -0.16M -1.46M
Depreciation 0.95M 0.96M 0.50M 0.44M 0.43M
Other cashflows from investing activities - -0.16M -0.15M -0.18M -0.58M
Change to account receivables 1.01M -1.20M -0.45M 0.36M -0.71M
Sale purchase of stock - - - - 0.00M
Other cashflows from financing activities -0.28M -0.36M -0.16M -0.08M -0.04M
Change to netincome - - - -0.23M -0.19M
Capital expenditures 0.09M 0.44M 0.38M 0.47M 0.70M
Change in working capital -0.04M 2.01M -0.09M 0.42M -0.56M
Stock based compensation - 0.19M 0.83M 0.02M 0.01M
Other non cash items 0.45M -0.18M -0.02M -0.23M -0.19M
Free cash flow 2.79M 0.81M 1.01M -0.62M -1.42M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RHT
Resonance Health Ltd		 -0.00
1.10%		 0.09 - 15.29 2.30 3.13 2.15 14.13
PME
Pro Medicus Ltd		 -4.52
2.18%		 202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd		 -0.06
2.53%		 2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd		 0.12
3.30%		 3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd		 -0.14
3.91%		 3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Resonance Health Ltd

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; HepaFatSmart, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFatSmart into a consolidated report; and CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading. It also provides phantoms comprising FerriScan, T1CMR, and T2CMR phantoms for the calibration of MRI machines. In addition, the company operates as an imaging contract research organization that provides comprehensive proposal and project management support, site set-up, imaging charter development, clinical reports, data transfer agreements, and compliance services for clinical trial sponsors. It serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

141 Burswood Road, Burswood, WA, Australia, 6100

61 8 9286 5300

https://www.resonancehealth.com

Name Title Year Born
Mr. Mitchell M. Wells B.Com., B.Comm, L.L.B., LLB MD, Joint Company Sec. & Exec. Director 1975
Mr. Nicholas Allan A.C.A., B.Com. CFO, COO & Joint Company Sec. NA
Mr. Ben Winters Chief Technology Officer NA
Ms. Liesl Ellies Gen. Counsel & Joint Company Sec. NA
Mr. Chad Tondut Communications Mang. and GM of Products & Portfolio NA
Mr. Ajay Nair Gen. Mang. of Global Sales & Marketing NA
Dr. John Olynyk BMedSc, FRACP, M.D., MBBS Chief Medical Officer NA
Dr. Timothy Guy St. Pierre B.Sc(Hons), Ph.D. Chief Research Scientist NA
Dr. Wenjie Pang Ph.D. Chief Scientific Officer ? Imaging & AI NA
Dr. Sherif Boulos Ph.D. Chief Scientific Officer of Molecular NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…